Collaborations: Mersana continues to advance its Johnson & Johnson and Merck KGaA ... in the same location following the ...
Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...
© 2024 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback